Clinical trial
Randomized Evaluation of fleCAinide Safety Versus STandard of Care in Patients With Coronary Artery Disease and Atrial Fibrillation
NCT07405671 is registered in ClinicalTrials.gov with Universitaire Ziekenhuizen KU Leuven as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Evaluation of fleCAinide Safety Versus STandard of Care in Patients With Coronary Artery Disease and Atrial Fibrillation
- Lead sponsor
- Universitaire Ziekenhuizen KU Leuven
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- September 30, 2026
- Completion date
- December 31, 2029
- Enrollment
- 988 (estimated)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.
atrial fibrillation (af), coronary artery disease